SC
TMCI icon

Stephens Consulting’s Treace Medical Concepts TMCI Stock Holding History

Stephens Consulting’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-473
Closed -$3.17K – 515
2025
Q3 		$3.17K Buy
+473
New +$3.09K ﹤0.01% 302
2025
Q2 		– Sell
-45
Closed -$378 – 1935
2025
Q1 		$378 Buy
+45
New +$404 ﹤0.01% 1151

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Stephens Consulting's TMCI Position: Q4 2025 in Review

Stephens Consulting sold out of Treace Medical Concepts (TMCI) in Q4 2025, closing a stake of 473 shares — an estimated $3.17K sold.

Stephens Consulting first reported a position in TMCI in Q1 2025 and held it in 2 quarters. The position peaked at $3.17K in Q3 2025. 115 funds tracked by Wall St. Rank hold TMCI as of Q4 2025.

  • Stephens Consulting reported no remaining Treace Medical Concepts position as of Q4 2025 after selling out during the quarter.
  • Stephens Consulting sold 473 Treace Medical Concepts shares in Q4 2025, an estimated $3.17K.
  • Stephens Consulting first reported a position in Treace Medical Concepts in Q1 2025 and held it in 2 quarters.
  • Stephens Consulting's Treace Medical Concepts position peaked at $3.17K in Q3 2025.
  • 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q4 2025.

Based on Stephens Consulting's 13F filing for Q4 2025, filed 13 Jan 2026.